Table 2.
The area under the ROC curve by binary logistic regression analysis (2 classes classification)
| Clinical scenario | A + versus A- (stage 1–6) | A + versus A- (stage 1–3) | Stage 1–3 vs. 4–6 in A+ | ||||
|---|---|---|---|---|---|---|---|
| Cases number | n = 371 | n = 258 | n = 143 | ||||
| Variable | Model | AUC | accuracy | AUC | accuracy | AUC | accuracy |
| Combined-panel | a | 0.949 | 0.895 | 0.949 | 0.911 | 0.608 | 0.594 |
| Combined-panel (by 5 PCA) | a | 0.938 | 0.871 | 0.948 | 0.891 | 0.596 | 0.573 |
| pTau217 | a | 0.944 | 0.865 | 0.947 | 0.876 | 0.651 | 0.566 |
| pTau181 | a | 0.859 | 0.784 | 0.855 | 0.771 | 0.580 | 0.573 |
| GFAP | a | 0.834 | 0.771 | 0.821 | 0.802 | 0.605 | 0.559 |
| pTau217 & pTau181 | a | 0.941 | 0.860 | 0.931 | 0.891 | 0.637 | 0.566 |
| pTau217 & pTau181 (PCA) | a | 0.912 | 0.825 | 0.914 | 0.837 | 0.625 | 0.566 |
| pTau217 & GFAP | a | 0.939 | 0.863 | 0.944 | 0.872 | 0.642 | 0.601 |
| pTau217 & GFAP (PCA) | a | 0.914 | 0.860 | 0.923 | 0.872 | 0.644 | 0.601 |
| pTau181 & GFAP | a | 0.866 | 0.817 | 0.860 | 0.837 | 0.591 | 0.559 |
| pTau181 & GFAP (PCA) | a | 0.873 | 0.827 | 0.868 | 0.829 | 0.607 | 0.566 |
| Combined-panel | b | 0.946 | 0.889 | 0.945 | 0.911 | 0.567 | 0.566 |
| Combined-panel (by 6 PCA) | b | 0.932 | 0.871 | 0.935 | 0.888 | 0.575 | 0.545 |
| pTau217 | b | 0.942 | 0.871 | 0.942 | 0.864 | 0.604 | 0.552 |
| pTau181 | b | 0.855 | 0.782 | 0.839 | 0.779 | 0.536 | 0.566 |
| GFAP | b | 0.825 | 0.760 | 0.806 | 0.795 | 0.549 | 0.539 |
| pTau217 & pTau181 | b | 0.939 | 0.879 | 0.927 | 0.876 | 0.594 | 0.573 |
| pTau217 & pTau181 (PCA) | b | 0.910 | 0.822 | 0.893 | 0.829 | 0.605 | 0.559 |
| pTau217 & GFAP | b | 0.937 | 0.871 | 0.939 | 0.868 | 0.605 | 0.580 |
| pTau217 & GFAP (PCA) | b | 0.897 | 0.852 | 0.895 | 0.872 | 0.631 | 0.587 |
| pTau181 & GFAP | b | 0.861 | 0.819 | 0.849 | 0.833 | 0.550 | 0.524 |
| pTau181 & GFAP (PCA) | b | 0.844 | 0.811 | 0.825 | 0.810 | 0.593 | 0.566 |
Accuracy is computed by the cut probability = 0.5
2 classes indicated amyloid positive (A+) or negative (A-) status
ROC: receiver operating characteristic, AUC: area under the ROC curve, PCA: Principal component analysis, GFAP, glial fibrillary acidic protein; NFL, neurofilament light chain
Model a includes only the listed test variable
Model b includes test variable and age, gender, educational years
A + versus A- (stage 1–6):
Combined-panel equation = 6.318
pTau217) + 0.022
pTau181)-54.52
(Aβ42/40)-0.072
NFL) + 0.003
GFAP) -0.267
(Total tau). Combined-panel (by PCA5 or PCA6) (scores computed on the first 5 or 6 principal components)
(I) By PCA_Combined-panel equation = 1.747
(pTau217) + 1.610
pTau181) − 0.652
(Aβ42/40) – 3.071
NFL) + 0.942
GFAP) − 0.617
(Total tau)
(II) By PCA_Combined-panel equation = − 0.875
PC1–2.676
PC2 + 2.364
PC3 + 1.804
PC4–0.039
PC5
A + versus A- (stage 1–3):
Combined-panel equation = 12.071
pTau217)-0.042
pTau181)-57.85
(Aβ42/40)-0.065
NFL) + 0.003
GFAP) -0.038
(Total tau)
(I) By PCA Combined-panel equation = 1.95
pTau217) − 1.459
pTau181) − 0.579
(Aβ42/40) – 3.903
NFL) + 0.758
GFAP) − 0.036
(Total tau)
(II) By PCA Combined-panel equation = 0.573
PC1–2.915
PC2–2.283
PC3 + 0.414
PC4 + 2.806
PC5
Stage 1–3 vs. 4–6 in A+:
Combined-panel equation = 1.51
pTau217)-0.019
pTau181) + 26.322
(Aβ42/40) + 0.006
NFL) + 0.001
GFAP) + 0.004
(Total tau)
(I) By PCA Combined-panel equation = 0.202
pTau217) − 0.175
pTau181) + 0.173
(Aβ42/40) + 0.123
NFL) + 0.371
GFAP) + 0.0004
(Total tau)
(II) By PCA Combined-panel equation = − 0.375
PC1 + 0.24
PC2 + 0.175
PC3–0.045
PC4 + 0.152
PC5